GE Healthcare Technologies

GEHC · NASDAQ

$70.23+$0.47 (+0.67%)TodayMarket closed ·
Prev close $69.76

Latest news

  • Press releaseBusiness Wire

    GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging

  • Press releaseBusiness Wire

    GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performance

  • Press releaseBusiness Wire

    Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow

  • Press releaseBusiness Wire

    GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68

  • Press releaseBusiness Wire

    GE HealthCare to announce third quarter 2026 results on October 28, 2026

  • NewsPiero Cingari

    Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseGlobe Newswire

    GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Press releaseBusiness Wire

    GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Press releaseBusiness Wire

    GE HealthCare announces cash dividend increase for third quarter of 2026

  • Press releaseBusiness Wire

    GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Press releaseBusiness Wire

    GE HealthCare Announces CareIntellect for Operations, Helping Health Systems Optimize Resources and Expand Access to Care

  • NewsCrispus Nyaga

    GE Healthcare in Talks To Acquire Sofie Biosciences, Maker of Cancer Scan Chemicals

  • Press releaseBusiness Wire

    GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA

  • Press releaseBusiness Wire

    GE HealthCare’s Photonova™ Spectra gains CE Mark, expanding international access

  • Press releaseBusiness Wire

    GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings

  • Press releaseBusiness Wire

    GE HealthCare management to present at upcoming investor conference

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseGlobe Newswire

    GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Press releaseBusiness Wire

    GE HealthCare appoints William Grogan as Chief Financial Officer

  • Press releaseBusiness Wire

    GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family

  • Press releaseBusiness Wire

    GE HealthCare expands breast imaging portfolio with Invenia ABUS Prime and launch of ABUS StreamVue

  • Press releasePRNewswire

    GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • NewsVandana Singh

    GE HealthCare Hits Record Backlog, Stock Jumps

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseBusiness Wire

    GE HealthCare reports second quarter 2026 financial results

  • Press releaseBusiness Wire

    GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum

  • NewsVandana Singh

    GE HealthCare Faces Pressure From Inflation And Tariffs

  • News

    GE HealthCare Techs Q1 2026 Earnings Call: Complete Transcript

  • Press releaseBusiness Wire

    GE HealthCare reports first quarter 2026 financial results

  • Press releaseBusiness Wire

    GE HealthCare reports fourth quarter and full year 2025 financial results

  • Press releaseBusiness Wire

    GE HealthCare reports third quarter 2025 financial results

  • Press releaseBusiness Wire

    GE HealthCare reports second quarter 2025 financial results

  • Press releaseBusiness Wire

    GE HealthCare reports first quarter 2025 financial results

  • Press releaseBusiness Wire

    GE HealthCare reports fourth quarter and full year 2024 financial results

  • Press releaseBusiness Wire

    GE HealthCare reports third quarter 2024 financial results

  • Press releaseBusiness Wire

    GE HealthCare reports second quarter 2024 financial results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.